You are here: Industry Insights > RDIF

News List

Sputnik V vaccine efficacy is 91.4 per cent: RDIF, Gamaleya Center expresspharma
December 15, 2020
Based on the data obtained at the third control point, the Gamaleya Center will create a report that will be used to submit for accelerated registration of the Sputnik V vaccine in various countries.
Dr Reddy’s and RDIF begin clinical trials for Sputnik V vaccine in India expresspharma
December 02, 2020
The clinical trials are being conducted by JSS Medical Research as the clinical research partner.
RDIF and Hetero agree to produce over 100 million doses of Sputnik V vaccine in India expresspharma
November 27, 2020
The parties intend to start the production of Sputnik V in the beginning of 2021.
The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets prnasia
November 26, 2020
The Russian Direct Investment Fund announces the cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, which is less than $20 for the two doses necessary to vaccinate one person.
Russian says its ‘Sputnik V’ COVID-19 vaccine is 92% effective pharmatimes
November 12, 2020
A COVID-19 vaccine developed by the Gamaleya Center in Russia is 92% effective, the Russian Direct Investment Fund (RDIF) said yesterday.
RDIF and União Química file documents for registration of Sputnik V vaccine with regulator in Brazil worldpharmanews
November 02, 2020
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), União Química Farmacêutica Nacional and the Government of the State of Paraná announce the pre-submission of preliminary documents to Brazil's National Health Surveillance Agency..
Russian application of Sputnik V vaccine for WHO vaccine prequalification among the first applications submitted worldpharmanews
October 29, 2020
The Russian Direct Investment Fund, (RDIF, Russia's sovereign wealth fund), has submitted applications to the World Health Organization (WHO) for accelerated registration (Emergency Use Listing, EUL) and prequalification of the world's first registered...
Dr Reddy’s, RDIF get DCGI nod for Phase II/III clinical trials of COVID-19 vaccine Sputnik V in India expresspharma
October 19, 2020
This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study.
RDIF and Trinity Pharma to supply 25 mn doses of Sputnik V vaccine to Nepal expresspharma
October 09, 2020
The agreement will enable 90 per cent of the population of Nepal to get access to Sputnik V vaccine.
RDIF and ChemRar agree to supply Avifavir to 17 countries pharmaceutical-technology
September 27, 2020
The Russian Direct Investment Fund (RDIF) and ChemRar Group will be supplying a Covid-19 drug, Avifavir, to 17 countries.

Previous page 1 2 3 4 5 Next page